⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVTY News
Revvity, Inc.
Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt USA - Deutsch USA - Français USA - English APAC - English USA - English USA - čeština
prnewswire.com
AMGN
ILMN
VRTX
RIVN
TROW
PRGS
ALNY
REGN
GILD
BMY
MRK
ABBV
AZN
SNY
NVS
XRAY
EVTC
MYGN
RVTY
VTRS
BIIB
MDLZ
PFE
SNDX
EXAS
CRSP
NTRA
ON
IDXX
MDT
SYK
ISRG
DXCM
COO
AMZN
GOOG
MSFT
NVDA
IBM
INTC
QCOM
AMD
MU
ADBE
CRM
ORCL
SAP
CSCO
ACN
HPQ
DELL
MSCI
FIS
PAYX
ADP
BBBY
ROST
TJX
MCHP
NXPI
SNPS
CDNS
WDC
STX
KLAC
LRCX
AMAT
CTAS
PAYC
NOW
DDOG
ZS
PANW
FTNT
SNOW
PYPL
V
MA
AXP
BAC
JPM
WFC
C
GS
MS
SCHW
ELAN
ZTS
ALGN
XOM
CVX
KO
PEP
MCD
DIS
CMCSA
VZ
T
NFLX
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team USA - English APAC - English USA - English
prnewswire.com
AMGN
VRTX
ILMN
RVTY
MYGN
TROW
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
businesswire.com
RVTY
LLY
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
businesswire.com
RVTY
Revvity to Present at Upcoming Investor Conferences
businesswire.com
RVTY
Revvity Announces Financial Results for the Third Quarter of 2025
businesswire.com
RVTY
Revvity Showcases Progress with Purpose in 2025 Impact Report
businesswire.com
RVTY
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
businesswire.com
RVTY
Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
prnewswire.com
RVTY
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
businesswire.com
RVTY
RVTY